Morgan Stanley raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $462 from $459 and keeps an Equal Weight rating on the ...

Vertex continues to capitalize on its leadership in cystic fibrosis (CF) treatments, where its blockbuster drug Trikafta is ...

Vertex Pharmaceuticals sees early success with Journavx painkiller, potential revenue growth from drug and gene therapy.

The global Tax Tech Market will grow from USD 18.53 billion in 2024 to USD 36.72 billion by 2030 at a compounded annual ...

Sikandar Advance Booking: Salman Khan, Rashmika Mandanna movie sells 26,000 tickets in top national chains with 4 days to go Jake Gyllenhaal Reveals Why He Needed to Be ‘Safe’ During ...

Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Vertex, Inc. (NASDAQ:VERX – Free Report) by 53.4% during the fourth quarter, according to its most recent disclosure ...

This advantage is partly due to the specialized nature of tax content, likening Vertex’s market position to that of a vertical SaaS provider ... company’s core strengths despite reduced bottom-line ...

In Morgan's response, he called the issue "a lie," while praising his community's and schools' handling of the situation and condemning Neimberg for even bringing the issue up at all. "I'm really ...

“Ashley Parker is not capable of doing a fair and unbiased interview,” Trump wrote on Truth Social. “She is a Radical Left Lunatic, and has been as terrible as is possible for as long as I have known ...